Ligand Pharmaceuticals Incorporated Business Operations Contracts & Agreements
20 Contracts & Agreements
- Collaboration Agreements (2 contracts)
- Cooperation Agreements (1)
- Development Agreements (2)
- Settlement Agreements (1)
- Supply Agreements (11)
- Termination Agreements (1)
- Voting Agreements (2)
- Supply agreement, dated December 22, 2015, by and between Cydex Pharmaceuticals, Inc. and Gilead Sciences, Inc (Filed With SEC on February 24, 2021)
- Amendment to Supply Agreement, dated September 21, 2020, by and between Cydex Pharmaceuticals, Inc. and Gilead Sciences, Inc., which amends that certain Supply Agreement, dated... (Filed With SEC on November 6, 2020)
- Development Funding and Royalties Agreement, dated December 13, 2018, by and between Ligand Pharmaceuticals Incorporated and Palvella Therapeutics, Inc (Filed With SEC on February 28, 2019)
- Cooperation Agreement, dated August 9, 2018, by and between Vernalis plc and Ligand Holdings UK Ltd (Filed With SEC on August 9, 2018)
- SUPPLY AGREEMENT BETWEEN CYDEX PHARMACEUTICALS, INC. AND CURX PHARMACEUTICALS, INC. DATED: August 12, 2013 TABLE OF CONTENTS (Filed With SEC on November 8, 2013)
- SUPPLY AGREEMENT (Filed With SEC on May 8, 2013)
- SUPPLY AGREEMENT BETWEEN CYDEX PHARMACEUTICALS, INC. AND ELI LILLY AND COMPANY DATED: December 16, 2011 TABLE OF CONTENTS (Filed With SEC on February 23, 2012)
- SUPPLY AGREEMENT (Filed With SEC on August 8, 2011)
- SUPPLY AGREEMENT (Filed With SEC on August 8, 2011)
- CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on March 3, 2011)
- 2nd Amendment to the CAPTISOL® SUPPLY AGREEMENT dated as of December 20, 2002 and amended July 29, 2005 BY AND BETWEEN CYDEX, INC. AND THE HOVIONE GROUP Dated as of March 1, 2007... (Filed With SEC on March 3, 2011)
- CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on March 3, 2011)
- CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on March 3, 2011)
- AMENDMENT NO. 2 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on November 9, 2009)
- RESEARCH COLLABORATION TERMINATION AGREEMENT (Filed With SEC on November 9, 2009)
- VOTING AGREEMENT (Filed With SEC on October 28, 2009)
- VOTING AGREEMENT (Filed With SEC on August 24, 2009)
- By and Between PHARMACOPEIA, INC. and SCHERING CORPORATION Table of Contents i COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on March 16, 2009)
- By and Between PHARMACOPEIA, INC. and SCHERING-PLOUGH LTD. Table of Contents i COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on March 16, 2009)
- SETTLEMENT AGREEMENT AND MUTUAL RELEASE OF ALL CLAIMS (Filed With SEC on November 7, 2008)
